2024 Society for Neuro-Oncology (SNO) / American Society of Clinical Oncology (ASCO) CNS Metastases Conference

2024 Society for Neuro-Oncology (SNO) / American Society of Clinical Oncology (ASCO) CNS Metastases Conference is organized by Society for Neuro-Oncology (SNO) and will be held from Aug 08 - 10, 2024 at Sheraton Denver Downtown Hotel, Denver, Colorado, United States of America.

Description:
The theme for this year’s conference is to bring together all the key stakeholders and leverage multi-sector collaborations to disrupt barriers and streamline therapeutic advances for patients with CNS metastases.

As an adjunct to the cutting-edge multidisciplinary science that will be presented, we expect the conference in Denver will provide an outstanding and unparalleled forum for networking and socialization with like-minded colleagues from around the world who are focused on advancing CNS metastases research and patient care, as well as the opportunity to interact with exhibitors from SNO’s industry and non-profit partners.

Topics:
Topics to be addressed include:
• Basic and translational research
• Radiation therapy
• Surgery
• Chemotherapy
• Targeted therapy/immunotherapy
• Multimodality therapy and clinical trials

Educational Objectives:
After attending this conference, participants should be able to:
• Explain the CNS activity of systemic agents in the context of multidisciplinary care for the treatment of CNS metastases.
• Discuss the evolving role of novel agents with enhanced CNS penetration.
• Discuss new developments in local therapeutic approaches and diagnostics in the treatment of CNS metastases.
• Explain the role of the tumor microenvironment in CNS metastases.
• Discuss innovative clinical trials designs incorporating recent advances such as liquid biopsy, novel prognostic biomarkers, and advanced neuroimaging for the treatment of CNS malignancies.
• Outline challenges for the development and approval of novel therapies for CNS cancers.